Abstract

Background: MS is a neurodegenerative autoimmune disease resulting from a complex interaction of genetic and environmental factors. Among these, vitamin D and genetic variants associated with vitamin D-metabolism gain great attention. The aim of our study was to assess five SNPs in NADSYN1 and CYP2R1 genes in relation to serum 25-OH-vitamin D3 levels in MS patients and controls. Methods: 25-OH-vitamin D3 levels and genotyping of CYP2R1- and NADSYN1-SNPs were investigated both in MS patients and in healthy controls. Results: The analysis revealed lower 25-OH-vitamin D3 concentrations in MS patients than in controls and an association of rs10766197 CYP2R1 SNP with MS risk. After stratifying MS patients according to gender, we found that the minor allele A of rs10766197 had a higher frequency in men in comparison to women affected by MS. Additionally, the presence of allele A in men was associated with disease progression, assessed by EDSS and MSSS scores. Conclusion: The findings of our study open new perspectives for a role of CYP2R1 in both risk and progression of MS, with sex-related differences.
Lingua originaleEnglish
pagine (da-a)297-304
Numero di pagine8
RivistaJournal of Neuroscience Research
Volume96
Stato di pubblicazionePublished - 2018

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience

Fingerprint Entra nei temi di ricerca di 'Association of CYP2R1 rs10766197 with MS risk and disease progression'. Insieme formano una fingerprint unica.

  • Cita questo